PH18108A - Olefinic benzimidazoles - Google Patents

Olefinic benzimidazoles

Info

Publication number
PH18108A
PH18108A PH28738A PH28738A PH18108A PH 18108 A PH18108 A PH 18108A PH 28738 A PH28738 A PH 28738A PH 28738 A PH28738 A PH 28738A PH 18108 A PH18108 A PH 18108A
Authority
PH
Philippines
Prior art keywords
benzimidazoles
olefinic
olefinic benzimidazoles
Prior art date
Application number
PH28738A
Other languages
English (en)
Inventor
Tina Marie Morwick
Charles Johnson Paget Jr
James Howard Wikel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH18108A publication Critical patent/PH18108A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH28738A 1982-04-08 1983-04-05 Olefinic benzimidazoles PH18108A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/366,760 US4420479A (en) 1982-04-08 1982-04-08 Olefinic benzimidazoles, formulations, and antiviral methods

Publications (1)

Publication Number Publication Date
PH18108A true PH18108A (en) 1985-03-22

Family

ID=23444387

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28738A PH18108A (en) 1982-04-08 1983-04-05 Olefinic benzimidazoles

Country Status (18)

Country Link
US (1) US4420479A (fi)
EP (1) EP0091795A1 (fi)
KR (1) KR840004409A (fi)
AU (1) AU1322483A (fi)
CA (1) CA1197245A (fi)
DD (1) DD209624A5 (fi)
DK (1) DK152883A (fi)
ES (2) ES521318A0 (fi)
FI (1) FI831191L (fi)
GB (1) GB2119789B (fi)
GR (1) GR78168B (fi)
IL (1) IL68299A0 (fi)
NZ (1) NZ203798A (fi)
PH (1) PH18108A (fi)
PL (3) PL247908A1 (fi)
PT (1) PT76499B (fi)
RO (1) RO86319B (fi)
ZA (1) ZA832410B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
JP2787539B2 (ja) * 1993-02-26 1998-08-20 松森  昭 ウイルス性疾患の予防または治療剤
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5475109A (en) * 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5545653A (en) * 1995-06-07 1996-08-13 Eli Lilly And Company Anti-viral compounds
CN1220601A (zh) * 1996-06-05 1999-06-23 伊莱利利公司 抗病毒化合物
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds
KR100539030B1 (ko) 1996-08-12 2005-12-27 셀진 코포레이션 면역치료제 및 이를 이용하여 사이토카인 농도를 감소시키는 방법
WO1998031363A1 (en) * 1997-01-22 1998-07-23 Eli Lilly And Company Anti-viral compounds
AU7715198A (en) * 1997-06-04 1998-12-21 Eli Lilly And Company Anti-viral compounds
US7470723B2 (en) 2003-03-05 2008-12-30 Celgene Corporation Diphenylethylene compounds and uses thereof
BRPI0408005A (pt) 2003-03-05 2006-02-14 Celgene Corp composto, composição farmacêutica, métodos para inibir angiogênese, atividade de pde4 em uma célula e proliferação de célula de cáncer, para inibir ou reduzir polimerização de tubulina ou estabilidade de tubulina em uma célula, para tratar ou melhorar um distúrbio inflamatório, um cáncer e um distúrbio do sistema nervoso central e para visar, bloquear ou destruir a função de vasculatura de tumor e o endotélio de vasos de tumor
BRPI0514857A (pt) 2004-09-03 2008-05-06 Celgene Corp composto ou um sal, solvato ou hidrato farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos para inibir a angiogênese, para inibir ou reduzir a polimerização da tubulina ou a estabilidade da tubulina em uma célula, para inibir a atividade de pde4 em uma célula, para inibir atividade do fator-alfa de necrose de tumor (tnf-alfa) em uma célula, para tratar ou melhorar um distúrbio inflamatório, para tratar ou melhorar cáncer, para inibir a proliferação de célula cancerosa, para marcar, bloquear ou destruir a função de vasculatura tumoral, para marcar, bloquear ou destruir o endotélio de vasos tumor, para marcar, bloquear ou destruir a função de vasculatura tumoral e inibir a angiogênese em um tumor e para tratar ou melhorar um distúrbio do sistema nervoso central
CN108997158B (zh) * 2018-07-16 2020-12-15 青岛科技大学 一种实现二取代酰胺与二苯基甲酮偶联的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018790A (en) * 1975-05-08 1977-04-19 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
GR61627B (en) * 1975-08-28 1978-12-04 Lilly Co Eli Preparation process of carbonyl-substituted 1-sulfonylbenzimidazoles
US4174454A (en) * 1975-08-28 1979-11-13 Eli Lilly And Company Alkylidenylmethyl-substituted 1-sulfonylbenzimidazoles
CA1076582A (en) * 1975-10-28 1980-04-29 Charles J. Paget Antiviral thiazolinyl or thiazinyl ketobenzimidazoles
US4008243A (en) * 1975-11-19 1977-02-15 Eli Lilly And Company Antiviral thiazolinyl or thiazinyl benzimidazole esters
US4118573A (en) * 1975-11-24 1978-10-03 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles
GR66420B (fi) * 1976-12-15 1981-03-20 Lilly Co Eli
US4230868A (en) * 1979-04-17 1980-10-28 Eli Lilly And Company α-Alkyl-α-hydroxybenzyl-substituted 1-sulfonylbenzimidazoles
US4316021A (en) * 1979-08-13 1982-02-16 Eli Lilly And Company Substituted 1-sulfonylbenzimidazoles

Also Published As

Publication number Publication date
GB2119789A (en) 1983-11-23
AU1322483A (en) 1983-10-13
FI831191A0 (fi) 1983-04-08
PT76499B (en) 1986-03-18
CA1197245A (en) 1985-11-26
DD209624A5 (de) 1984-05-16
ZA832410B (en) 1984-11-28
FI831191L (fi) 1983-10-09
NZ203798A (en) 1985-07-12
RO86319A (ro) 1985-03-15
KR840004409A (ko) 1984-10-15
RO86319B (ro) 1985-03-31
DK152883A (da) 1983-10-09
ES8502097A1 (es) 1984-12-16
PL247908A1 (en) 1985-01-16
ES8505966A1 (es) 1985-06-01
ES534218A0 (es) 1985-06-01
GR78168B (fi) 1984-09-26
DK152883D0 (da) 1983-04-06
US4420479A (en) 1983-12-13
PL241385A1 (en) 1984-09-24
IL68299A0 (en) 1983-07-31
ES521318A0 (es) 1984-12-16
PL247909A1 (en) 1984-12-17
EP0091795A1 (en) 1983-10-19
PT76499A (en) 1983-05-01
GB2119789B (en) 1985-08-29

Similar Documents

Publication Publication Date Title
GB8325360D0 (en) Benzimidazoles
GB8508826D0 (en) Silical-alumina cogels
GB2119789B (en) Olefinic benzimidazoles
GB8322151D0 (en) Splitter-bifurcate arrangement
GB8300403D0 (en) Semiconductor arrangement
DE3360576D1 (en) Antimycosic agents
ZA829422B (en) Hyperuretic agents
HK85491A (en) Current-discrimination arrangement
DE3361358D1 (en) Anthelmintics
DE3379497D1 (en) Anthelmintics
ZA836296B (en) Anthelmintics
GB8312557D0 (en) O-phenylenediamine
ZA832638B (en) Benzimidazole derivatives
DE3168547D1 (en) Benzimidazoles
CS462782A1 (en) Zarizeni pro rozvolnovani vlaken v ojednocovacim telese spradaci jednotky
IE822640L (en) Benzimidazoles
EP0110872A3 (en) Hypsometer i
CS269283A2 (en) Zarizeni pro posuv pasu materialu opatreneho registracnimi i znackami
CS899283A1 (en) Zpusob odstraneni ztrat v dutych vlaknech dialyzatoru
CS201083A1 (en) Zarizeni k cisteni elektricke podlozky elektrostatickeho obrazu v kopirovacich pristrojich
CS533982A1 (en) Zpusob vyroby suroveho zeleza v sachtovem reaktoru z pevne vsazky
CS319882A1 (en) Sposob osetrenia dlazky kotercov v porodniach osipanych
CS262582A1 (en) Sposob stanovenia koncentracie farbiacich prostriedkov v polylefinoch
CS591782A1 (en) Automaticke vkladaci zarizeni sadby predpestovane v pestebnich bunkach
CS782082A1 (en) Ulozenie dopravnika v prednom lozisku